BioSpeech
Curated by SignalAssistive communication technologies and Sleep apnea diagnostic device
Overview
Biospeech develops assistive communication technologies for people with a wide range of communication challenges. The company is developing a a computer tool to assist clinicians in performing detailed and more reliable disfluency counts. The company is also developing a Speech Mimicry software that mimics an individual's ability to produce speech that mimics the individual’s pre-morbid speech. Furthermore, biospeech is developing a portable, low-cost, and minimally obtrusive system for automatically detecting sleep-disordered breathing, such as cessation of breathing (apnea). The system will enable early and frequent screening for sleep-disordered breathing in a patient’s home. The National Institutes of Health have invested $3.4M in BioSpeech since 2009.
Key facts
- Founded
- 2004
- Headquarters
- Portland, United States
- Stage
- Sign up to view
- Industry
- Life Sciences Technology
Business model
- 3 products and services
- Sign up to view
Contact
- Primary office
- Sign up to view